Q1 2025 · 13F-HR
Lepercq De Neuflize Asset Management LLCholdings as filed
Filed 2025-05-13 · accession 0001420506-25-000994
$103.3M
Reported value
14
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $64.5M | 62.4% | 115,245 | Common | SOLE |
| 464287465 | EFA | ISHARES TR | $38.1M | 36.9% | 466,000 | Common | SOLE |
| 514766104 | LFCR | LIFECORE BIOMEDICAL INC | $138,688 | 0.13% | 19,700 | Common | SOLE |
| 58471G508 | MDGSUSD | XYLO TECHNOLOGIES LTD | $127,950 | 0.12% | 26,059 | Common | SOLE |
| 961881208 | WETH | WETOUCH TECHNOLOGY INC | $98,533 | 0.10% | 67,954 | Common | SOLE |
| 18270P109 | CLAR | CLARUS CORP NEW | $83,250 | 0.08% | 22,200 | Common | SOLE |
| 74102L303 | SQFTEUR | PRESIDIO PPTY TR INC | $77,122 | 0.07% | 134,125 | Common | SOLE |
| 294100102 | ENZB | ENZO BIOCHEM INC | $57,832 | 0.06% | 156,303 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $50,086 | 0.05% | 31,700 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $31,598 | 0.03% | 23,234 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $29,210 | 0.03% | 23,000 | Common | SOLE |
| 068221100 | BRN | BARNWELL INDS INC | $24,300 | 0.02% | 15,000 | Common | SOLE |
| 250639101 | DSWL | DESWELL INDS INC | $23,550 | 0.02% | 10,000 | Common | SOLE |
| 50186A132 | — | LGL GROUP INC | $8,381 | 0.01% | 26,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.